Develop first-in-class therapies for millions of people whose daily lives are limited by allergies Biotech

About IgGenix

IgGenix is tracked on 100Xfounder as a startup company, founded in 2019, based in San Francisco Bay Area, California, USA, currently mapped to the Series B stage. Develop first-in-class therapies for millions of people whose daily lives are limited by allergies Biotech

Profile snapshot: Founders linked: IgGenix Team. Funding tracked: $40.00M. Hiring focus: Open Roles. Tech tags: AWS, React, Python, and PostgreSQL.

Recent signals:

  • IgGenix appears in the 100Xfounder startup directory import feed.

Why it Matters

IgGenix is worth tracking because its funding history is already mapped here, including a $40.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and IgGenix Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $40.00MLast Round: Series B Khosla Ventures, $40M Series B in 2023All Rounds: 1
  • Series B | Khosla Ventures, $40M Series B in 2023

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

AWSReactPythonPostgreSQL

Last updated: June 1, 2026

IgGenix research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

  • Company summary

    Develop first-in-class therapies for millions of people whose daily lives are limited by allergies Biotech

  • Founders covered

    IgGenix Team

  • Market position

    Startup | Series B | San Francisco Bay Area, California, USA

  • Newsroom signal

    No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.

  • Funding signal

    $40.00M

Best next clicks

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Startup with comparable market signals.

Discover Now

Newsroom and topic pages connected to IgGenix.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About IgGenix

Common questions people ask about this profile.

What is IgGenix?

Develop first-in-class therapies for millions of people whose daily lives are limited by allergies Biotech

Who founded IgGenix?

IgGenix is associated with IgGenix Team on 100Xfounder.

Where is IgGenix located?

IgGenix is listed in San Francisco Bay Area, California, USA.

What stage is IgGenix in?

IgGenix is currently mapped to Series B. Funding context: Khosla Ventures, $40M Series B in 2023

What is the latest funding round of IgGenix?

IgGenix's latest tracked round is Series B Khosla Ventures, $40M Series B in 2023. Total tracked rounds: 1.

Is IgGenix hiring now?

IgGenix hiring status: Open Roles.

What technologies does IgGenix use?

IgGenix is associated with AWS, React, Python, and PostgreSQL.

Is IgGenix verified on 100Xfounder?

Yes. IgGenix is currently marked verified on 100Xfounder as of June 1, 2026.

How can users connect with IgGenix founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.